Archive of Cancer investigation (ACI) is an international, peer-reviewed, open-access journal dedicated to advancing scientific understanding and improving clinical outcomes in all areas of cancer research. Our mission is to foster collaboration among scientists, clinicians, and healthcare professionals worldwide to accelerate progress in cancer prevention, early detection, diagnosis, and therapy.

Scope

ACI welcomes high-quality contributions that explore the biological, clinical, and translational dimensions of oncology. The journal seeks to bridge the gap between basic research and clinical application, promoting innovations that enhance patient care and global cancer control.

We publish original research articles, systematic reviews, meta-analyses, short communications, and case reports covering, but not limited to, the following areas:

• Molecular and Cellular Oncology – signaling pathways, gene regulation, tumor biology, and cellular mechanisms of transformation and metastasis
  
• Cancer Genetics and Genomics – genomic profiling, precision medicine, biomarkers, and hereditary cancer syndromes
  
• Tumor Immunology and Immunotherapy – immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies
  
• Experimental and Translational Oncology – preclinical studies, animal models, and translational insights bridging laboratory and clinical settings
  
• Clinical Oncology – diagnostic imaging, surgical oncology, radiotherapy, chemotherapy, and targeted therapies
  
• Cancer Pharmacology and Drug Development – novel therapeutic agents, pharmacogenomics, and resistance mechanisms
  
• Cancer Epidemiology and Public Health – risk factors, prevention strategies, and population-based cancer studies
  
• Supportive and Palliative Care – quality of life, survivorship, and integrative oncology approaches
  

The journal also encourages submissions addressing AI and computational oncology, liquid biopsy technologies, precision diagnostics, and oncology informatics — reflecting the evolving frontiers of modern cancer science.

Editorial and Ethical Standards

All manuscripts undergo a rigorous double-blind peer-review process by at least two independent experts to ensure scientific integrity, originality, and methodological soundness.

ACI adheres to the ethical guidelines of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE). All research involving human participants or animals must have appropriate ethical approval and informed consent.

Open Access and Licensing

ACI operates under a fully open-access model, ensuring immediate and unrestricted access to all published content.
All articles are distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, sharing, adaptation, and redistribution in any medium, provided the original work is properly cited.

In line with the Budapest Open Access Initiative (BOAI) and the Directory of Open Access Journals (DOAJ) principles:

• There are no embargo periods for publication.
  
• Full-text access does not require registration or payment.
  
• The digital version is permanently free and available worldwide.
  
• Authors retain full copyright while granting the journal the right to publish under CC BY 4.0.
  

This commitment to open science promotes transparency, equity, and the rapid dissemination of oncology research to benefit clinicians, researchers, and patients globally.

Publication Details

• Publisher: [To be inserted]
  
• Frequency: Quarterly
  
• Language: English
  
• Peer Review: Double-blind
  
• Publication Fees: No article processing charges (APCs)
  
• License: Creative Commons Attribution (CC BY 4.0)
  

Vision

The Journal of Cancer Archive strives to be a leading global platform for cancer scholarship—advancing discovery, fostering collaboration, and empowering innovation toward a world where cancer prevention and treatment are informed by the best available science.